Review examines the structure and bioproduction of fungal immunomodulatory proteins, revealing their immune-modulating benefits.
Fungal immunomodulatory proteins (FIPs) are low-molecular-weight proteins from macrofungi that share the potential to modulate immune responses. Structurally, they fall into five subgroups, with the Fve-type and Cerato-type being the most representative. Originally, these proteins evolved in fungi for mycoparasitism and defense; their immunomodulatory, antitumor, anti-inflammatory, and hepatoprotective effects validated in human cells and animal models are surprisingly beneficial. Post-translational modifications and specific oligomeric states regulate the FIP functionality. These structural features critically govern receptor engagement and downstream signaling, whereby FIPs orchestrate immune responses via Toll-like receptor/NF-κB modulation and exert antitumor effects through EGF receptor/Akt interference. Recent advances in genomic mining and bioinformatics have accelerated novel FIP discovery, while scalable production is now achievable through optimized heterologous expression systems incorporating solubility-enhancing tags, promoter engineering, endotoxin removal, and tailored fermentation. This review examines the structure-activity relationships, mechanism-driven bioactivities, and bioproduction platforms of FIPs, highlighting their potential in biopharmaceutical and functional food applications.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: